|
1. Biologie
|
|
|
|
|
4.5 Dép., diag. & prono. - Colorectal
|
|
|
|
5.12 Immunothérapies
|
|
|
|
5.2 Pharma
|
|
|
|
5.2.3 Pharma - économie
|
|
|
|
5.3 Traitements - FDA, EMA,...
|
|
|
|
|
|
5.3.4 Traitements - AMM (FDA, EMA)
|
|
|
|
5.4 Traitements - Economie
|
|
|
|
5.6 ESMO
|
|
|
|
6.10 Politiques
|
|
|
|
6.10.1 Politiques (USA)
|
|
|
Biden: What I Learned About Cancer [The Cancer Letter]
|
|
|
|
|
|
And
the cost of lifesaving drugs is astronomical. We have to come up with a
better way. What is the possible justification when a drug a lifesaving
drug is brought to market at the time it’s brought to market it costs
$26,000 a year, and 15 years later it costs $120,000? Tell me, tell
me—tell me, what is the justification for that?
|
|
|
|
|
|
|
|
6.11 Patients
|
|
|
Well: At the End of Life, What Would Doctors Do? [NY Times]
|
|
|
|
|
|
In
any event, the public’s interest in the medical treatments that doctors
choose must not be allowed to reinforce our culture’s tendency to see
dying solely through medical lenses. More to the point is the question,
how do dying doctors live?
|
|
|
|
|
|
|
6.7.2 Applis
|
|
|
|
6.9 Controverses
|
|
|